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DNA is an unstable molecule that is prone to lesions, which arise continuously due to environmental agents or reactive species produced by the endogenous metabolism. Despite the existence of numerous repair systems, some lesions escape repair and remain in the DNA during genome replication, which often results in a replication block. Polymerase eta (Pol eta) belongs to the Y family of specialized DNA polymerases, which are able to catalyze nucleotide incorporation opposite lesions that cannot be bypassed by a high-fidelity replicative DNA polymerase. This TLS (TransLesion Synthesis) polymerase plays an important role in cellular protection against the toxic and mutagenic effects of UV radiation and it is the primary enzyme responsible for the efficient and accurate bypassing of cyclobutane pyrimidine dimers, which are the major type of DNA lesions induced by UV (Johnson et al., 1999a; Masutani et al., 1999). Accordingly, mutations in the human gene encoding Pol eta cause XP-V syndrome, which frequently leads to skin cancer (Masutani et al. 1999; Johnson et al., 1999; Di Lucca et al., 2009). In addition to UV lesions, Pol eta is able to bypass a variety of lesions in vitro (Kusumoto et al., 2002; Pollack et al., 2006; Haracska et al., 2000a; Haracska et al., 2000b; Vaisman et al., 2000; Minko et al., 2001). It is also implicated in the replication of structured regions that occur naturally in DNA (Betous et al., 2009, Bergoglio et al., 2013). However, while replicating undamaged DNA templates, Pol eta produces base substitutions with an extremely high frequency (Johnson et al., 2000; Matsuda et al., 2000; McCulloch & Kunkel, 2008). Additionally, Pol eta can bypass some DNA lesions in an error-prone manner, and this process is also a molecular mechanism underlying the generation of mutations (Zhang et al., 2000). Therefore, the access of Pol eta to the replication fork must be strictly regulated. Numerous studies have highlighted the central role of the replication processivity clamp (PCNA) in the mechanism by which TLS DNA polymerases gain access to DNA and replace the replicative polymerases in incorporation of nucleotides opposite the damaged base. In response to DNA replication block and exposure of ssDNA, Lys164 of PCNA is monoubiquitinated by the E2/E3 complex Rad6-Rad18 (Hoege et (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Hoege%20C%5BAuthor%5D&cauthor=true&cauthor_uid=12226657​) al., 2002). Pol eta interacts with the interconnecting loop of PCNA via its PCNA-interacting protein (PIP) motif (Haracska et al, 2001a; Haracska et al., 2001b; Haracska et al., 2002). Additionally, Pol eta interacts functionally with monoubiquitinated-PCNA via its ubiquitin-binding domain UBZ, which facilitates its recruitment to the replication fork (Bienko et al., 2005). In higher eukaryotes, access of Pol eta to the replication fork is further modulated by the posttranslational phosphorylation and ubiquitination of the polymerase protein (Göhler et al., 2011). Cellular abundance also appears to be an important factor in the function of Pol eta, as not only defects of  RAD30/POLH/XPV but also overexpression of this gene causes detectable phenotypes. Overexpression of POLH  from high copy number episomal vectors was reported to cause a toxic effect in human cells (Thakur et al., 2001).  It has also been recently shown, that abnormal up-regulation of human Pol eta through IRF1 transactivation is responsible for mutation frequency increase and carcinogenesis in cells exposed to alkylating agent MNNG (Qi et al., 2012). Consistently, a global analysis of the status of POLH in skin cancer cells demonstrated that, in a cohort of patients showing no changes in their POLH DNA sequences, the expression level of Pol eta mRNA was either decreased or increased in skin tumor tissue compared with normal tissue (Flanagan et al., 2007). The significance of the regulation of Pol eta abundance in the maintenance of genetic stability has been especially well documented in S. cerevisiae. In yeast devoid of Pol eta, UV-induced mutagenesis and survival are affected (McDonald et al., 1997; Johnson et al., 1999b; Yu et al., 2001; Podlaska et al., 2003; McIntyre et al., 2006). On the other hand, overexpression of the RAD30 gene, encoding the yeast Pol eta, significantly increases the mutation frequency in nucleotide excision repair-deficient S. cerevisiae that have been chronically exposed to low doses of UV (Haruta et al., 2012). While the overexpression-mediated mutagenesis caused by chronic low-dose UV exposure depends on the function of the polymerase active center, an increase in spontaneous mutagenesis can be caused by overproduction of both active Pol eta and a catalytically inactive mutated form of the polymerase (Pavlov et al., 2001). This finding suggests that direct misincorporation by yeast Pol eta is not the only possible mechanism underlying the increased mutagenesis associated with the overproduction of this protein. Importantly, the mutator effect connected with Pol eta overproduction in yeast is strongly enhanced in cells with defective proofreading activity of polymerase epsilon or mismatch repair, indicating that an excess of this polymerase causes replication infidelity. However, there are conflicting reports concerning the post-transcriptional regulation of Pol eta in yeast. The results from Skoneczna et al. (2007) suggest that Rad30 is a short-lived protein with a half-life of ca. 30 min. In contrast, according to Pabla et al. (2008), Pol eta is a stable protein. Here, we have undertaken a study to clarify these discrepancies and further characterize the factors regulating the cellular abundance of Pol eta in yeast. We established the half-life of native Pol eta in S. cerevisiae and demonstrated that both the stability and cellular abundance of the nzyme are cell cycle stage dependent.

2. Materials and methods
2.1. Yeast strains and plasmids. Most of the mRNA and protein analyses were performed in BY4741 (MATa his3 leu2 met15ura3) and its derivatives. The YSC1178-7500027 strain (BY4741 derivative) encoding a C-terminally TAP-tagged Rad30 was purchased from Open Biosystems. The Y003 strain encoding a C-terminally 9Myc-tagged Rad30 was kindly provided by Helle Ulrich (Parker et al., 2007). The pMP2 plasmid encoding a GFP-RAD30 fusion under the control of the Met25 promoter was constructed via ligation of the RAD30 ORF (PCR amplified with the forward primer 5’TTTCCCGGGATGTCAAAATTTACTTGG and the reverse primer 5’ TTTCTCGAGGGAATAGGTCATTTTTTTC) with the pUG34 N-terminal GFP-fusion plasmid (J.H. Hegemann, Heinrich-Heine-Universität, Düsseldorf, Germany) using XhoI and SmaI restriction sites.
2.2. Growth conditions for the determination of cellular protein levels, half-lives and mRNA levels. Yeast strains were grown in YPD or synthetic complete liquid medium at 30°C (or 23°C, where indicated) until they reached a density of 2-3×107 cells/ml. Then, 2 ml or 30 ml of the culture was collected via centrifugation for the preparation of either a protein or RNA extract, respectively. Cultures of BY4741 derivatives carrying a disrupted RAD30 (rad30::kanMX4) and transformed with either pUG34 (control vector) or pMP2 (encoding GFP-RAD30), were grown in synthetic complete liquid medium supplemented with 0.3 mM methionine. At this concentration of methionine, expression of the fusion gene from the MET25 promoter assured the production of GFP-Rad30 at the level  comparable with  production of Pol eta from its natural promoter, as was established by western blot. To determine the half-life of Rad30, cultures were supplemented with cycloheximide (CHX) at a final concentration of 100 µg/ml. 
2.3. Cell synchronization. Logarithmically growing yeast (OD600 0.15-0.2) were arrested in G1 through treatment with α factor for 2 h at 23°C. α factor was added to cultures in two portions at 2 µg/ml, first at the beginning of synchronization and then after 1 h of incubation. For the cell cycle progression experiments, α factor was washed out 3 times with water, and the cells were resuspended in fresh YPD medium. For G2 arrest, the yeast cultures were synchronized for 2 h with 20 µg/ml nocodazole. 
2.4. Western blotting. For immunoblot analysis of the tagged forms of Pol eta, we employed the method previously described by Skoneczna et al. (2007). TAP-tagged polypeptides were detected by incubating the membranes with a rabbit peroxidase-anti-peroxidase affinity-isolated antibody (PAP, Sigma-Aldrich). Myc- and GFP-tagged polypeptides were detected by incubating membranes with either an anti-Myc (Covance) or anti-GFP (Invitrogen) primary antibody, respectively, followed by incubation with a goat anti-mouse horseradish peroxidase-conjugated IgG secondary antibody (HRP, DAKO). For biochemical visualization of G2 phase in synchronized cells, Clb2 was detected with an anti-Clb2 primary antibody (sc-9071, Santa Cruz), followed by incubation with a goat anti-rabbit IgG HRP-conjugated secondary antibody (HRP, Santa Cruz). As a reference, phosphoglycerate kinase (PGK) was detected by incubating the membranes with a mouse anti-Pgk1 monoclonal primary antibody (Invitrogen), followed by incubation with the secondary antibodies indicated above. 
Blots for native Pol eta were blocked overnight at 4°C using a 1:1 mixture of NAP blocker buffer (non-animal protein, G-Bioscience) in TBST. Then, the membranes were incubated for 1.5-2 h at room temperature with a mixture of equal volumes of the SC-11868 and SC-11866 Santa Cruz primary antibodies, diluted 1:3,000 in an NAP-TBST mixture (1:3). This was followed by 2 h incubation with goat anti-mouse HRP IgG (HRP, DAKO) at a 1:20,000 dilution. To avoid the majority of nonspecific binding, both the primary and secondary antibodies were purified prior to use via incubation with 200-400 µl of a BY4741 rad30::kanMX4 cell extract for 2 h at room temperature.
Signal detection was performed using chemiluminescent substrates for HRP (SuperSignal West Pico, Thermo Scientific) or, in the case of native Pol eta, highly sensitive West Femto (Thermo Scientific) and a CCD gel imager (Alpha Innotech). The resulting bands were quantified using ImageJ 1.47 (NIH, USA). The quantification procedure always included normalization to Pgk1. 
2.5 Total RNA extraction and real-time quantitative PCR (RT-qPCR) analysis. A total of 30 ml of the culture was harvested via centrifugation, then washed with 1 ml of water and centrifuged again. The supernatant was immediately aspirated, and the cells were frozen in liquid nitrogen and kept at -80°C. Total RNA was extracted as described in http://www.wi.mit.edu/young/expression.html (​http:​/​​/​www.sciencedirect.com​/​science?_ob=RedirectURL&_method=externObjLink&_locator=url&_issn=00928674&_origin=article&_zone=art_page&_plusSign=%2B&_targetURL=http%253A%252F%252Fwww.wi.mit.edu%252Fyoung%252Fexpression.html" \t "externObjLink​). Removal of contaminating genomic DNA and reverse transcription (RT) were performed using the QuantiTect Reverse Transcription Kit (QIAGEN, Germany), according to the manufacturer’s recommendations. Quantitative-PCR amplification was conducted using a LightCycler 1.5 and LightCycler FastStart DNA Master SYBR Green I (Roche Diagnostics GmbH, Germany), according to the manufacturer’s instructions. Data normalization was carried out against the transcripts of the ACT1 housekeeping gene. The sequences of all primers and the qPCR amplification parameters are available upon request.
2.6 Flow cytometry. Yeast cells harvested from 1 ml of a synchronized culture were suspended in 70% ethanol and stored at -20°C until analysis on a Becton Dickinson FACSCalibur flow cytometer. On the day of analysis, the cells were washed two times with sodium citrate (50 mM, pH 7.2), then incubated in 1 ml of sodium citrate for 1 h at 55°C with RNAse A (250 µg/ml) and subsequently for 1 h with proteinase K (1 mg/ml). Finally, the cells were stained for 1 h with propidium iodide (160 µg/ml) at RT and sonicated thoroughly to eliminate aggregates. 

3. Results
3.1. C-terminal tags affect the stability of Pol eta. The low abundance of Pol eta in yeast cells as well as difficulties in detecting the protein with commercially available antibodies have resulted in the use of tagged forms of this protein in all but one study published to date. Consequently, the stability of Pol eta in yeast cells has been inferred from investigations of fusion proteins carrying various epitopes at the Pol eta C-terminus (Skoneczna et al., 2007; Pabla et al., 2008). We hypothesized that the discrepancies in the data regarding the half-life of Pol eta could reflect differences in the stabilities of the various fusion proteins being analyzed. Therefore, we reinvestigated the stability of the frequently employed constructs Rad30-TAP and Rad30-9Myc, both of which carry epitopes at their C-termini. Our results confirmed that the half-life of Rad30-TAP was ca. 30 min. In contrast, we found that Pol eta-9Myc was a relatively stable protein (Fig. 1AB and Fig. S1BC). These results strongly suggest that at least some modifications of the unstructured C-terminus of Pol eta may affect the stability of the protein. 
To determine the stability of native Pol eta, we developed a protocol enabling detection of the untagged enzyme (see Methods2.4 and Fig. S2). As shown in Fig. 2, the native protein appeared to be less stable than Rad30-9Myc but more stable than Rad30-TAP, showing a half-life of 80±14 min as determined through densitometry measurements and half-life calculations performed according to Belle et al. (2006). We also noticed, that the stability of Pol eta N-terminally tagged with GFP was comparable to that of untagged Pol eta (mean half-life = 90±32 min, Fig. 1C). 
3.2. Pol eta abundance depends on the cell cycle stage. The ability to detect unmodified Pol eta, produced from its native promoter, led us to investigate whether the cellular abundance of this TLS polymerase is subject to cell cycle regulation. BY4741 yeast cells were arrested in G1 using α factor and then released to proceed synchronously throughout the cell cycle (Fig. 3). Progression through the cell cycle was monitored via FACS analysis of DNA contents, and G2 phase was detected by monitoring Clb2 accumulation. In these experiments, yeast cultures were grown at 23°C to slow cell cycle progression. We found the levels of Pol eta to be lowest in G1 and early S phase. We noted that although Pol eta began to accumulate in late S phase, its abundance increased as most cells attained a G2 content of DNA peaking in early M phase. In G2/M, the cellular abundance of Pol eta was over 3-fold higher than in early S phase. 
To determine whether the fluctuations in Pol eta levels were accompanied by changes in the expression of the RAD30 gene, the level of RAD30 mRNA was investigated in various stages of the cell cycle. RT-qPCR analysis revealed no significant differences in RAD30 mRNA levels between cells in G1, S or G2 or cells arrested in G2/M with nocodazole (Fig. 4). This result pointed to the role of posttranscriptional mechanisms in the regulation of Pol eta abundance throughout the cell cycle. 
3.3. The stability of Pol eta is cell cycle regulated. Next, we investigated whether the cell cycle regulation of Pol eta abundance was the result of cell cycle stage dependent changes in the stability of the enzyme. We established that in yeast cells arrested in G1 with α factor, the Pol eta half-life was 38±10 minutes, which is over two-fold shorter than the half-life established for asynchronously growing cells (Fig. 5A). Upon arrest at the G2/M boundary with nocodazole, the stability of Pol eta increased over four fold compared with its stability in G1, reaching a half-life of 162±55 min. To analyze Pol eta stability in S and G2, we released yeast cells from α factor arrest and blocked protein synthesis through the addition of cycloheximide in either middle S phase (40-60 min after α factor release), or in G2 (80-100 min after α factor release) (Fig. 5B). The mean Pol eta half-lives in the late S and G2 phases, calculated for different time points after the cycloheximide-mediated inhibition of protein synthesis, were 166± 64 and 175±50 min, respectively. It is worth noting that while the stabilities of Pol eta determined for independent cultures in G1 were not significantly different, the differences between independent cultures in both late S and G2 phases were much more pronounced. To better understand the stabilization of Pol eta in S phase, we added cycloheximide to yeast cells 20 min after α factor release (Fig. 5C). At that stage of early S phase, the DNA content, analyzed via FACS, was not significantly different from that in G1 cells. However, at this stage as opposed to G1, the addition of a protein synthesis inhibitor did not block cell cycle progression through S phase. When protein synthesis was inhibited in early S phase, Pol eta remained unstable throughout all of S phase until cells reached G2, indicating that Pol eta stabilization in S/G2 depends on a protein factor synthesized in early S phase. 
4. Discussion 
Functioning of TLS polymerases is tightly regulated at different levels. Recently, increasing interest has been focused on the posttranslational regulation of these enzymes. The results presented here indicate an apparent dependence of Pol eta stability on the cell cycle stage in S. cerevisiae. The regulation of the cellular abundance and stability of Pol eta in yeast was previously addressed by several laboratories (Skoneczna et al., 2007, Pabla et al., 2008). However, the investigations into protein stability published to date have employed fusion forms of Pol eta that carry various epitopes at the C-terminus. Our results indicate that the C-terminal tags differ strikingly in their effects on Pol eta half-life pointing to the conformation of the Pol eta C-terminus as an important factor influencing Pol eta stability. Importantly, these results indicate the necessity of investigating the native form of Pol eta. 
Here, we optimized the procedure for Pol eta detection in yeast extracts, which allowed us to estimate the endogenous level of native Pol eta throughout the cell cycle and led to the unexpected discovery that Pol eta abundance is regulated in a cell cycle-dependent manner. The pattern of Pol eta cell cycle regulation is clearly different from the one known for replicative polymerases and resembles the pattern previously established for Rev1 (Waters and Walker, 2006), which is the only other Y family TLS polymerase that functions in yeast. For both enzymes, the lowest level is detected in G1 and early S phase and the highest level in G2/M. This bias in polymerase abundance throughout the cell cycle indicates an increased cellular capacity for translesion synthesis in G2. This finding is consistent with a current concept of DNA damage tolerance, according to which TLS is present predominantly in late S or G2, in single-stranded gaps left behind the replication fork across damage in DNA template (Karras et al., 2010; Daigaku et al., 2010). However, we cannot exclude that the pattern of Pol eta cellular abundance changes after treatment with DNA damaging agents. It was previously shown, that  the level of Rad30 mRNA increases several fold after UV treatment (McDonald eta al., 1997, Roush et al., 1998, Pabla et al., 2008). There is possibility that this is to help facilitate TLS at times when steady state  levels of Pol eta are lower during the cell cycle. It was also implicated, based on the study with TAP-tagged Pol eta that the level and stability of this polymerase increase in response to UV treatment (Skoneczna et al., 2007). In light of our present results, one can presume that the accumulation and stabilization of Pol eta may just reflect slowing down of S phase and/or activation of G2 checkpoint in response to UV. This presumption requires, however, further verification. The regulation of native Pol eta in response to DNA damage during cell cycle will be a subject of future investigations.
Another surprising observation coming out of the analysis of cell cycle regulation of Rev1is that the accumulation of these TLS polymerases proceeds further beyond G2 into M phase (Waters and Walker, 2006). Our results also suggest, that Pol eta accumulation proceeds beyond the “no return” prometaphase checkpoint, suggesting an as yet unknown function of TLS polymerases in mitosis.
Although the general trend of accumulating TLS polymerases in G2/M is common to both Pol eta and Rev1, the extent of this accumulation is strikingly different between them. The level of Pol eta is increased 3 fold in G2/M relative to G1 and early S. In contrast, the relative increase shown for Rev1 was 50 fold (Waters and Walker, 2006). However, the large difference between the relative accumulation of Pol eta and Rev1 in G2/M does not necessarily mean that Rev1 prevails over Pol eta in that phase of the cell cycle. Taking  in consideration the presence of over 3.5-fold excess of Pol eta molecules, as compared to Rev1, per cell in logarithmically growing asynchronous yeast cultures (Ghaemmaghami et al., 2003) together with a cell cycle composition of logarithmic cultures and the distributions of both polymerases in cell cycle, it appears that Pol eta still slightly prevails over Rev1 in G2/M. Additionally, in all other phases yeast cells exhibit significant levels of Pol eta, which do not fall below that of Rev1 at its G2/M peak. This in turn strongly suggests that in addition to its role in filling post-replicative single-stranded DNA gaps, Pol eta performs other functions throughout the cell cycle. The capacity of Pol eta to function in all cell cycle stages has also been postulated in mammalian cells, as it was shown that this polymerase could be recruited to sites of DNA damage, independent of the cell cycle stage (Soria et al., 2009). Additionally, several non-TLS roles for Pol eta during the cell cycle have been postulated (for review see Sale et al., 2012). 
Our results indicate that the cell cycle regulation of Pol eta abundance in unstressed  yeast is not accompanied by changes in the levels of RAD30 mRNA. In this respect, the regulation of Pol eta differs from that of Rev1, whose mRNA is 3-fold more abundant in G2 than in G1. The cell cycle regulation of Pol eta levels appears to be exclusively posttranscriptional, proceeding at the level of protein stability. We established that the stability of Pol eta in G2/M is over four-fold higher than in G1. Additionally, as recently demonstrated by Wiltrout and Walker (2011), the stability of Rev1 is also increased in G2 relative to G1. Therefore, we conclude that cell cycle-dependent stability control is a general property of Y family TLS polymerases in S. cerevisiae.
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Figure 1. The stability of differently tagged forms of Rad30. Results of CHX-chase experiments with Rad30-TAP (A), Rad30-9Myc (B) and GFP-Rad30 (C). Western blots of representative experiments (A, B, C left); densitometric quantification of Pol eta western blots using data from the left panels. Band intensities were normalized to the respective Pgk1 bands and to t=0 (A, B, C right).

Figure 2. The stability of Pol eta in BY4741. Results of CHX-chase experiments with native (untagged) Rad30. Western blots from a representative experiment (top); plot of the exponential trend line of Rad30 stability (regression coefficient R2=0.97). Band intensities were normalized to the respective Pgk1 bands and to t=0. The data are the mean values from eight independent experiments ±SD (bottom).

Figure 3. The abundance of Pol eta in different stages of the cell cycle. Cells were arrested in G1 using  factor at 23°C and then released to proceed synchronously through the cell cycle. Representative western blots using antibodies against Rad30, Clb2 (as an indicator of G2 phase) and Pgk1 (as a loading control) are shown at the indicated time points following release from α factor-mediated G1 arrest (top left). FACS analysis of DNA content at the respective cell cycle stages (top right). Diagram of changes in Pol eta cellular abundance. Band intensities were normalized to the respective Pgk1 bands and to t=0. The presented data are the mean values from six independent experiments ±SD (bottom).

Figure 4. The level of Pol eta mRNA is cell cycle-independent. The relative levels of RAD30 mRNA and ACT1 (as a reference) were quantified via RT-qPCR in extracts prepared from cells that were first arrested in G1 with α factor and then released to proceed synchronously into S phase (60 min after α factor release) and G2 (80 min after α factor release) or were arrested in G2/M with nocodazole. The levels of RAD30 mRNA detected in S, G2 and G2/M were normalized to the respective levels of ACT1 mRNA, so that the RAD30 mRNA/ACT1 mRNA ratio in G1=1. The presented data are the mean values from three independent experiments ± SD (top). FACS analysis of the DNA contents of the analyzed yeast cells in G1, S, G2 or G2/M (bottom). 

Figure 5. The stability of Pol eta is cell cycle stage-dependent. Results of CHX-chase experiments with cells (A) arrested in G1 with α factor (top) or in G2/M with nocodazole  (bottom); (B) cells proceeding through middle S, 40 min after release from α factor arrest (top), or through G2, 80 min after release from α factor arrest (bottom). Nocodazole was added to the cultures 40 or 20 min after CHX treatment of cells in middle S or G2, respectively, to avoid mitosis; (C) cells in early S, 20 min after release from α factor arrest. (A, B, C) FACS analysis of DNA content at t=0 of CHX addition (left); representative western blots obtained using antibodies against Rad30 and Pgk1, as a loading control (center); mean half-lives calculated from 6-8 independent experiments ±SD (right).




